Thomann J
Division of Clinical Pharmacology and Toxicology, Department of Pharmaceutical Sciences, University of Basel , ,
ArticlePsilocybin
Acute psilocybin or ethocybin leads to a sustained increase in Pavlovian aversion memory in male mice
ArticlePsilocybin
Acute psilocybin or ethocybin leads to a sustained increase in Pavlovian aversion memory in male mice.
ArticlePsilocybin
Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.
ArticleKetamine
Development and Validation of a Rapid LC-MS/MS Method for Plasma Analysis of Ketamine, Norketamine, Dehydronorketamine, and Hydroxynorketamine.
ArticleMescaline
Pharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants.
ArticleLSD
Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial.
ArticleMescaline
Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects.
ArticlePsilocybin
<i>In vitro</i> and <i>in vivo</i> metabolism of psilocybin's active metabolite psilocin.
ArticlePsilocybin
Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.
ArticleMescaline